KEAP1-mutant lung cancers weaken anti-tumor immunity and promote an M2-like macrophage phenotype.
Single-cell RNA-seq · mouse · 15 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Mus musculus (mouse)
- Samples
- 15 samples: 15 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- KEAP1-Mutant Lung Cancers Weaken Anti-Tumor Immunity and Promote an M2-like Macrophage PhenotypeInternational journal of molecular sciences · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE250166_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1052294 and SRA study SRP477880. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 15 sample titles: 15 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7974911 LL2_WT.1 [aWT.1]
- GSM7974912 LL2_WT.3 [aWT.3]
- GSM7974913 LL2_WT.2 [aWT.2]
- GSM7974914 LL2_KEAPKO3.2 [K3F10.2]
- GSM7974915 LL2_KEAPKO3.3 [K3F10.3]
- GSM7974916 LL2_KEAPKO3.1 [K3F10.1]
- GSM7974917 LL2_KEAPKO2.2 [K3A3.2]
- GSM7974918 LL2_KEAPKO2.3 [K3A3.3]
- GSM7974919 LL2_KEAPKO2.1 [K3A3.1]
- GSM7974920 LL2_KEAPKO1.3 [K2B12.3]
- GSM7974921 LL2_KEAPKO1.2 [K2B12.2]
- GSM7974922 LL2_KEAPKO1.1 [K2B12.1]
- GSM7974923 LL2_NRF2KO.3 [N1D8.3]
- GSM7974924 LL2_NRF2KO.2 [N1D8.2]
- GSM7974925 LL2_NRF2KO.1 [N1D8.1]
- GSE286348 Macrophages foster anti-tumor immunity by ZEB1-dependent cytotoxic T cell chemoattraction 18 samples shares anti-tumor, macrophage, immunity
- GSE324687 Eomes sustains progenitor CD4⁺ T helper cells to promote anti-tumor immunity during immunotherapy [scRNA] 16 samples shares anti-tumor, immunity, promote
- GSE341921 PGK1 moonlights as an NF-kB/p65 kinase to orchestrate M2-like macrophage-mediated immunosuppression in triple-negative breast cancer 6 samples shares m2-like, macrophage
- GSE278990 Single-cell screens identify ADAM12 as a fibroblast checkpoint impeding anti-tumor immunity 73 samples shares anti-tumor, immunity
- GSE322775 Coordinated immune activation following KRAS inhibition reveals molecular pathways that potentiate and limit anti-tumor immunity 47 samples shares anti-tumor, immunity
- GSE306718 Macrophage Cluster of Differentiation 163 promotes post-infarction cardiac repair and preserves left ventricular function via osteopontin 37 samples shares macrophage, promote
- GSE316541 α2,6-Sialoglycan-regulated anti-tumor immunity of tumor-infiltrating CD8+ T cells in the tumor microenvironment [CD8+T] 27 samples shares anti-tumor, immunity
- GSE234974 Pan-cancer mapping of single CD8+ T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity I 24 samples shares anti-tumor, immunity
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.